Top

Published in:

01-08-2018 | Original Research

Challenges, Dilemmas and Factors Involved in PGD Decision-Making: Providers’ and Patients’ Views, Experiences and Decisions

Author: Robert Klitzman

Published in: Journal of Genetic Counseling | Issue 4/2018

Abstract

Providers and patients are considering and pursuing PGD for ever-more conditions, but questions arise concerning how they make, view and experience these decisions, and what challenges they may face. Thirty-seven in-depth semi-structured interviews were conducted (with 27 IVF providers and 10 patients). Patients and providers struggled with challenges and dilemmas about whether to pursue PGD in specific cases, and how to decide. Respondents varied in how they viewed, experienced and made these choices, and for which conditions to pursue PGD (from lethal, childhood-onset conditions to milder, treatable, or adult-onset disorders). Several factors were involved, including differences in gene penetrance, predictability, and phenotypic expression, and disease severity, age of onset, treatability, stigma and degree of disability. Providers and patients face questions regarding possibilities of screening for more than one condition in one set of embryos, and limitations of PGD (e.g., inaccurate results). Characteristics of providers (e.g., amount of PGD experience, understandings of genetics, and use of genetic counselors), and of patients (e.g., related to broader moral and social attitudes) can also affect these decisions. These data, the first to examine several key questions concerning PGD, suggest that providers and patients confront several dilemmas. These findings have critical implications for future practice, guidelines, education and research.

ACMG Board of Directors. (2015). Scope of practice: A statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 17(9), e3. https://doi.org/10.1038/gim.2015.94.CrossRef

Baruch, S., Kaufman, D., & Hudson, K. L. (2008). Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics. Fertility and Sterility, 89(5), 1053–1058. https://doi.org/10.1016/j.fertnstert.2007.05.048.

Cox, G. F., Burger, J., Lip, V., Mau, U. A., Sperling, K., Wu, B. L., & Horsthemke, B. (2002). Intracytoplasmic sperm injection may increase the risk of imprinting defects. American Journal of Human Genetics, 71(1), 162–164. https://doi.org/10.1086/341096.

Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr, (25), 59–66.

de Die-Smulders, C. E., Höweler, C. J., Thijs, C., Mirandolle, J. F., Anten, H. B., Smeets, H. J., et al. (1998). Age and causes of death in adult-onset myotonic dystrophy. Brain, 121(Pt 8), 1557–1563.

Derks-Smeets, I. A., Gietel-Habets, J. J., Tibben, A., Tjan-Heijnen, V. C., Meijer-Hoogeveen, M., Geraedts, J. P., … van Osch, L. A. (2014). Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: A challenge for couples with hereditary breast and ovarian cancer. Human Reproduction, 29(5), 1103–1112. https://doi.org/10.1093/humrep/deu034.

Drazba, K. T., Kelley, M. A., & Hershberger, P. E. (2014). A qualitative inquiry of the financial concerns of couples opting to use preimplantation genetic diagnosis to prevent the transmission of known genetic disorders. Journal of Genetic Counseling, 23(2), 202–211. https://doi.org/10.1007/s10897-013-9638-7.CrossRefPubMed

Ethics Committee of American Society for Reproductive Medicine. (2013). Use of preimplantation genetic diagnosis for serious adult onset conditions: A committee opinion. Fertility and Sterility, 100(1), 54–57. https://doi.org/10.1016/j.fertnstert.2013.02.043.CrossRef

Fauser, B. C., Devroey, P., Diedrich, K., Balaban, B., Bonduelle, M., Delemarre-van de Waal, H. A., et al. (2014). Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature. Reproductive BioMedicine Online, 28(2), 162–182. https://doi.org/10.1016/j.rbmo.2013.10.013.

Fiorentino, F., Bono, S., Biricik, A., Nuccitelli, A., Cotroneo, E., Cottone, G., et al. (2014). Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles. Human Reproduction, 29(12), 2802–2813. https://doi.org/10.1093/humrep/deu277.CrossRefPubMed

Geertz, C. (1973). Interpretation of cultures. New York: Basic Books.

Goetsch, A., Volk, A., & Woodruff, T. K. (2014). Genetic counselors: Bridging the Oncofertility information gap. In T. K. Woodruff, M. L. Clayman, & K. E. Waimey (Eds.), Oncofertility communication: Sharing information and building relationships across disciplines (pp. 87–98). New York: Springer New York.CrossRef

Goetsch, A. L., Wicklund, C., Clayman, M. L., & Woodruff, T. K. (2016). Reproductive Endocrinologists' utilization of genetic counselors for Oncofertility and preimplantation genetic diagnosis (PGD) treatment of BRCA1/2 mutation carriers. Journal of Genetic Counseling, 25(3), 561–571. https://doi.org/10.1007/s10897-015-9908-7.CrossRefPubMed

Grant, B. (2016). First MRT baby born. The Scientist. Retrieved from http://www.the-scientist.com/?articles.view/articleNo/47159/title/First-MRT-Baby-Born/.

Gregg, A. R., Gross, S. J., Best, R. G., Monaghan, K. G., Bajaj, K., Skotko, B. G., et al. (2013). ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine, 15(5), 395–398. https://doi.org/10.1038/gim.2013.29.CrossRefPubMed

Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., & Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening. Genetics in Medicine, 15(6), 482–483. https://doi.org/10.1038/gim.2013.47.CrossRefPubMed

Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59–82. https://doi.org/10.1177/1525822X05279903.CrossRef

Haude, K., McCarthy Veach, P., LeRoy, B., & Zierhut, H. (2016). Factors influencing the decision-making process and long-term interpersonal outcomes for parents who undergo preimplantation genetic diagnosis for Fanconi anemia: A qualitative investigation. Journal of Genetic Counseling. https://doi.org/10.1007/s10897-016-0032-0.

Jarvholm, S., Thurin-Kjellberg, A., & Broberg, M. (2017). Experiences of pre-implantation genetic diagnosis (PGD) in Sweden: A three-year follow-up of men and women. Journal of Genetic Counseling. https://doi.org/10.1007/s10897-017-0078-7.

Kalfoglou, A. L., Scott, J., & Hudson, K. (2005). PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis. Reproductive Biomedicine Online, 11(4), 486–496.CrossRefPubMed

Klitzman, R. (2016a). Buying and selling human eggs: Infertility providers' ethical and other concerns regarding egg donor agencies. BMC Medical Ethics, 17(1), 71. https://doi.org/10.1186/s12910-016-0151-z.CrossRefPubMedPubMedCentral

Klitzman, R. (2016b). Deciding how many embryos to transfer: Ongoing challenges and dilemmas. Reproductiive Biomedicine & Society Online, 3, 1–15. https://doi.org/10.1016/j.rbms.2016.07.001.CrossRef

Klitzman, R. (2016c). How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization. Fertility and Sterility, 106(1), 216–224. https://doi.org/10.1016/j.fertnstert.2016.03.030.CrossRefPubMed

Klitzman, R. (2016d). Reducing the number of fetuses in a pregnancy: Providers’ and patients’ views of challenges. Human Reproduction, 31(11), 2570–2576. https://doi.org/10.1093/humrep/dew231.CrossRef

Klitzman, R. (2016e). Struggles in defining and addressing requests for “family balancing”: Ethical issues faced by providers and patients. The Journal of Law, Medicine & Ethics, 44(4), 616–629. https://doi.org/10.1177/1073110516684804.CrossRef

Klitzman, R. (2017a). How much is a child worth? Providers' and patients' views and responses concerning ethical and policy challenges in paying for ART. PLoS One, 12(2), e0171939. https://doi.org/10.1371/journal.pone.0171939.CrossRefPubMedPubMedCentral

Klitzman, R. (2017b). Unconventional combinations of prospective parents: Ethical challenges faced by IVF providers. BMC Medical Ethics, 18(1), 18. https://doi.org/10.1186/s12910-017-0177-x.CrossRefPubMedPubMedCentral

Klitzman, R., Chung, W., Marder, K., Shanmugham, A., Chin, L. J., Stark, M., et al. (2013a). Attitudes and practices among internists concerning genetic testing. Journal of Genetic Counseling, 22(1), 90–100. https://doi.org/10.1007/s10897-012-9504-z.CrossRefPubMed

Klitzman, R., Chung, W., Marder, K., Shanmugham, A., Chin, L. J., Stark, M., et al. (2013b). Views of internists towards uses of PGD. Reproductive Biomedicine Online, 26(2), 142–147. https://doi.org/10.1016/j.rbmo.2012.11.006.CrossRefPubMed

Klitzman, R., Abbate, K. J., Chung, W. K., Ottman, R., Leu, C. S., & Appelbaum, P. S. (2014). Views of preimplantation genetic diagnosis among psychiatrists and neurologists. The Journal of Reproductive Medicine, 59(7–8), 385–392.PubMedPubMedCentral

Lavery, S. A., Aurell, R., Turner, C., Castello, C., Veiga, A., Barri, P. N., & Winston, R. M. (2002). Preimplantation genetic diagnosis: patients' experiences and attitudes. Human Reproduction, 17(9), 2464–2467.CrossRefPubMed

Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psychooncology, 14(12), 1060–1074. https://doi.org/10.1002/pon.933.CrossRefPubMed

Menon, U., Harper, J., Sharma, A., Fraser, L., Burnell, M., ElMasry, K., et al. (2007). Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Human Reproduction, 22(6), 1573–1577. https://doi.org/10.1093/humrep/dem055.CrossRefPubMed

National Academies of Sciences, Engineering, and Medicine, National Academy of Medicine, National Academy of Sciences, Committee on Human Gene Editing: Scientific, Medical, and Ethical Considerations (2017): Human Genome Editing: Science, Ethics and Governance. Washington, D.C.: The National Academies Press.

Ormondroyd, E., Donnelly L, C Moynihan, Savona, C., Bancroft, E., Evans, D. G., … M. Watson (2012). Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. European Journal of Human Genetics, 20, 4–10. https://doi.org/10.1038/ejhg.2011.146.

Quinn, G., Vadaparampil, S., Wilson, C., King, L., Choi, J., Miree, C., & Friedman, S. (2009). Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertility and Sterility, 91(6), 2361–2368. https://doi.org/10.1016/j.fertnstert.2008.03.019.CrossRefPubMed

Rich, T. A., Liu, M., Etzel, C. J., Bannon, S. A., Mork, M. E., Ready, K., et al. (2014). Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Familal Cancer, 13(2), 291–299. https://doi.org/10.1007/s10689-013-9685-0.CrossRef

Riley, B. D., Culver, J. O., Skrzynia, C., Senter, L. A., Peters, J. A., Costalas, J. W., et al. (2012). Essential elements of genetic cancer risk assessment, counseling, and testing: Updated recommendations of the National Society of genetic counselors. Journal of Genetic Counseling, 21(2), 151–161. https://doi.org/10.1007/s10897-011-9462-x.CrossRefPubMed

Ross, L. F., Saal, H. M., David, K. L., Anderson, R. R., & American Academy of, P., American College of Medical, G., & Genomics. (2013). Technical report: Ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15(3), 234–245. https://doi.org/10.1038/gim.2012.176.CrossRefPubMed

Salm, M., Abbate, K., Appelbaum, P., Ottman, R., Chung, W., Marder, K., et al. (2014). Use of genetic tests among neurologists and psychiatrists: Knowledge, attitudes, behaviors, and needs for training. Journal of Genetic Counseling, 23(2), 156–163. https://doi.org/10.1007/s10897-013-9624-0.CrossRefPubMed

Strauss, A., & Corbin, J. (1990). Basics of qualitative research: Techniques and procedures for developing grounded theory. Newbury Park: Sage Publications.

The Human Fertilisation and Embryology Authority. (2013). PGD conditions licensed by the HFEA. Retrieved from https://www.hfea.gov.uk/pgd-conditions/.

Wilton, L., Thornhill, A., Traeger-Synodinos, J., Sermon, K. D., & Harper, J. C. (2009). The causes of misdiagnosis and adverse outcomes in PGD. Human Reproduction, 24(5), 1221–1228. https://doi.org/10.1093/humrep/den488.CrossRefPubMed

Title: Challenges, Dilemmas and Factors Involved in PGD Decision-Making: Providers’ and Patients’ Views, Experiences and Decisions
Author: Robert Klitzman
Publication date: 01-08-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 4/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-017-0173-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Challenges, Dilemmas and Factors Involved in PGD Decision-Making: Providers’ and Patients’ Views, Experiences and Decisions

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Genesurance Counseling: Patient Perspectives

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit

Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives

“Second-Class Status?” Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome

Identification as a Mutation Carrier and Effects on Life According to Experiences of Finnish Male BRCA1/2 Mutation Carriers

Reproductive Decision Support: Preferences and Needs of Couples at Risk for Hereditary Cancer and Clinical Geneticists